|
FR2046920B1
(enExample)
|
1969-06-19 |
1974-05-03 |
Citizen Watch Co Ltd |
|
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
US4957939A
(en)
|
1981-07-24 |
1990-09-18 |
Schering Aktiengesellschaft |
Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
|
|
US4472509A
(en)
|
1982-06-07 |
1984-09-18 |
Gansow Otto A |
Metal chelate conjugated monoclonal antibodies
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
DE229046T1
(de)
|
1985-03-30 |
1987-12-17 |
Marc Genf/Geneve Ballivet |
Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
|
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
|
US4938948A
(en)
|
1985-10-07 |
1990-07-03 |
Cetus Corporation |
Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク，インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US20040049014A1
(en)
|
1988-12-28 |
2004-03-11 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
AU652539B2
(en)
|
1989-05-16 |
1994-09-01 |
Medical Research Council |
Co-expression of heteromeric receptors
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
JPH049249A
(ja)
|
1990-04-27 |
1992-01-14 |
Kusuda:Kk |
塗型剤吹き付け機
|
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
EP0571613B1
(en)
|
1991-12-13 |
2003-09-17 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
PT627940E
(pt)
|
1992-03-05 |
2003-07-31 |
Univ Texas |
Utilizacao de imunoconjugados para o diagnostico e/ou terapia de tumores vascularizados
|
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US20030148406A1
(en)
|
1992-03-17 |
2003-08-07 |
David John King |
Multivalent antigen-binding proteins
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
AU691811B2
(en)
|
1993-06-16 |
1998-05-28 |
Celltech Therapeutics Limited |
Antibodies
|
|
US5432930A
(en)
|
1993-09-30 |
1995-07-11 |
Eagle Crest Limited |
System for accessing cobol data files by generating a dictionary of NF.sup.2
|
|
NL9302194A
(nl)
|
1993-12-15 |
1995-07-03 |
Nidera Handelscompagnie B V |
Werkwijze voor het bereiden van een samengevoegd visprodukt, alsmede visprodukt verkregen onder toepassing van deze werkwijze.
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
DE19526926A1
(de)
|
1995-07-24 |
1997-01-30 |
Bayer Ag |
Verfahren zur Herstellung beladener nichtporöser Trägermaterialien
|
|
US7264963B1
(en)
|
1995-08-18 |
2007-09-04 |
Morphosys Ag |
Protein(poly)peptide libraries
|
|
ES2176484T3
(es)
|
1995-08-18 |
2002-12-01 |
Morphosys Ag |
Bancos de proteinas/(poli)peptidos.
|
|
AU7378096A
(en)
|
1995-09-28 |
1997-04-17 |
Alexion Pharmaceuticals, Inc. |
Porcine cell interaction proteins
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
US6596850B1
(en)
|
1998-01-30 |
2003-07-22 |
Ixsys, Incorporated |
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
|
WO2000023082A1
(en)
|
1998-10-19 |
2000-04-27 |
Yeda Research And Development Co. Ltd. |
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
|
|
US20040031072A1
(en)
*
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
WO2001002588A2
(en)
|
1999-07-02 |
2001-01-11 |
Morphosys Ag |
Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
|
|
IT1307309B1
(it)
|
1999-12-30 |
2001-10-30 |
Enea Ente Nuove Tec |
Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
|
|
CN1441676B
(zh)
|
2000-03-31 |
2012-08-22 |
普渡研究基金会 |
用配体-免疫原缀合物治疗的方法
|
|
DE10037759A1
(de)
|
2000-08-03 |
2002-07-04 |
Gruenenthal Gmbh |
Screeningverfahren
|
|
WO2002069232A2
(en)
|
2001-02-19 |
2002-09-06 |
Merck Patent Gmbh |
Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity
|
|
AU2002258518A1
(en)
|
2001-03-14 |
2002-09-24 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
CN101979095A
(zh)
|
2001-05-02 |
2011-02-23 |
普渡研究基金会 |
巨噬细胞介导的疾病的治疗和诊断
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
AU2003211337A1
(en)
|
2002-03-01 |
2003-09-16 |
Japan Envirochemicals, Ltd. |
Proteins capable of binding to female sex hormones and process for producing the same
|
|
NZ535425A
(en)
*
|
2002-03-13 |
2008-05-30 |
Biogen Idec Inc |
Anti-alphavbeta6 antibodies
|
|
US7531522B2
(en)
|
2002-04-22 |
2009-05-12 |
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
KR101317045B1
(ko)
*
|
2002-09-06 |
2013-10-16 |
암젠 인코포레이티드 |
치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체
|
|
WO2004043989A2
(en)
|
2002-11-07 |
2004-05-27 |
Medarex, Inc. |
Human monoclonal antibodies to heparanase
|
|
EP1481993A1
(en)
|
2003-05-28 |
2004-12-01 |
Xerion Pharmaceuticals AG |
Modulation of the poliovirus receptor function
|
|
WO2004082463A2
(en)
|
2003-03-17 |
2004-09-30 |
Medical College Of Ohio |
Folate receptor gene modulation for cancer diagnosis and therapy
|
|
US20050255114A1
(en)
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
CN1802388B
(zh)
|
2003-05-09 |
2011-01-05 |
杜克大学 |
Cd20特异抗体及使用它们的方法
|
|
CN1816356A
(zh)
|
2003-05-14 |
2006-08-09 |
免疫原公司 |
药物缀合物组合物
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
JP2008500949A
(ja)
|
2003-07-02 |
2008-01-17 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
|
CA2548942C
(en)
|
2003-12-05 |
2013-10-15 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health |
Anti-sars monoclonal antibodies
|
|
EP3101034A1
(en)
|
2004-02-12 |
2016-12-07 |
Morphotek, Inc. |
Monoclonal antibodies that specifically bind to folate receptor alpha
|
|
US20080187954A1
(en)
|
2004-03-10 |
2008-08-07 |
Lonza Ltd. |
Method For Producing Antibodies
|
|
WO2005103716A2
(en)
|
2004-04-27 |
2005-11-03 |
Galapagos N.V. |
Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
|
|
CA2581208A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US7811563B2
(en)
|
2004-10-25 |
2010-10-12 |
Northwestern University |
Anti-addl antibodies and uses thereof
|
|
AU2005337132B2
(en)
|
2004-12-21 |
2011-01-20 |
Monsanto Technology, Llc |
Transgenic plants with enhanced agronomic traits
|
|
WO2006071877A2
(en)
*
|
2004-12-27 |
2006-07-06 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally deliverable and anti-toxin antibodies and methods for making and using them
|
|
CN101120021A
(zh)
|
2004-12-31 |
2008-02-06 |
基因技术公司 |
结合br3的多肽及其用途
|
|
EP2153848A3
(en)
|
2005-01-27 |
2010-07-21 |
The Regents of the University of California |
Therapeutic monoclonal antibodies that neutralize botulinium neurotoxins
|
|
PT2343320T
(pt)
|
2005-03-25 |
2018-01-23 |
Gitr Inc |
Anticorpos anti-gitr e as suas utilizações
|
|
US7608413B1
(en)
|
2005-03-25 |
2009-10-27 |
Celera Corporation |
Kidney disease targets and uses thereof
|
|
ATE460668T1
(de)
|
2005-03-30 |
2010-03-15 |
Purdue Research Foundation |
Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren
|
|
CA2607444C
(en)
|
2005-04-22 |
2015-03-10 |
Morphotek, Inc. |
Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
|
|
EP1888639A1
(en)
|
2005-05-12 |
2008-02-20 |
Oncotherapy Science, Inc. |
Methods for damaging cells using effector function of anti-dsc2 antibody
|
|
EP1915394B1
(en)
|
2005-05-20 |
2021-01-27 |
Lonza Biologics plc. |
High-level expression of recombinant antibody in a mammalian host cell
|
|
BRPI0610203A2
(pt)
|
2005-05-24 |
2010-06-01 |
Avestha Gengraine Tech Pvt Ltd |
processo de preparação in vivo de anti-corpo monoclonal anti-cd 20 biologicamente ativo e composição farmacêutica
|
|
EP1904183B1
(en)
|
2005-07-05 |
2014-10-15 |
Purdue Research Foundation |
Pharmaceutical composition for the treatment of osteoarthritis
|
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
EP1937720B1
(en)
|
2005-08-18 |
2014-04-09 |
Ramot at Tel-Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
JP4938263B2
(ja)
|
2005-08-19 |
2012-05-23 |
独立行政法人農業生物資源研究所 |
一本鎖抗体によるサイトゾルタンパク質の機能阻害法およびその利用
|
|
PT1931710T
(pt)
*
|
2005-08-31 |
2017-03-28 |
Merck Sharp & Dohme |
Anticorpos anti-il-23 manipulados
|
|
ES2543341T3
(es)
|
2005-09-13 |
2015-08-18 |
National Research Council Of Canada |
Métodos y composiciones para modular la actividad de células tumorales
|
|
EP1938104A2
(en)
|
2005-10-17 |
2008-07-02 |
Institute for Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
NZ616992A
(en)
|
2005-12-20 |
2015-07-31 |
Sbi Biotech Co Ltd |
Anti-ilt7 antibody
|
|
WO2007109749A2
(en)
|
2006-03-21 |
2007-09-27 |
Wyeth |
Methods for preventing and treating amyloidogenic diseases
|
|
CA2685300C
(en)
|
2006-06-01 |
2017-01-03 |
Mayo Foundation For Medical Education And Research |
Immunity to folate receptors
|
|
ES2444695T3
(es)
|
2006-06-23 |
2014-02-26 |
Alethia Biotherapeutics Inc. |
Polinucleótidos y polipéptidos implicados en el cáncer
|
|
US7910702B2
(en)
|
2006-07-28 |
2011-03-22 |
The Governors Of The University Of Alberta |
Recombinant antibodies to sclerotinia antigens
|
|
AU2007284651B2
(en)
|
2006-08-09 |
2014-03-20 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
|
JP2010502224A
(ja)
*
|
2006-09-08 |
2010-01-28 |
アボット・ラボラトリーズ |
インターロイキン１３結合タンパク質
|
|
EP1900752A1
(en)
|
2006-09-15 |
2008-03-19 |
DOMPE' pha.r.ma s.p.a. |
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
|
CN103396486A
(zh)
|
2006-10-12 |
2013-11-20 |
中外制药株式会社 |
使用抗ereg抗体的癌症的诊断和治疗
|
|
CA2672581A1
(en)
|
2006-12-14 |
2008-06-19 |
Forerunner Pharma Research Co., Ltd. |
Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
|
|
EP2121756A4
(en)
|
2006-12-20 |
2011-08-31 |
Mmrglobal Inc |
ANTIBODIES AND PROCESS FOR THEIR PREPARATION AND USE
|
|
US20080227704A1
(en)
|
2006-12-21 |
2008-09-18 |
Kamens Joanne S |
CXCL13 binding proteins
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
US9216228B2
(en)
|
2007-02-16 |
2015-12-22 |
KTB Tumorforschungsgesellschaft MBM |
Receptor and antigen targeted prodrug
|
|
US20100104626A1
(en)
|
2007-02-16 |
2010-04-29 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
JP2010518858A
(ja)
*
|
2007-02-23 |
2010-06-03 |
シェーリング コーポレイション |
操作された抗−ｉｌ−２３ｐ１９抗体
|
|
US7915368B2
(en)
*
|
2007-05-23 |
2011-03-29 |
Bridgestone Corporation |
Method for making alkoxy-modified silsesquioxanes
|
|
WO2008145136A1
(en)
|
2007-05-30 |
2008-12-04 |
Aarhus Universitet |
Stat3 inactivation by inhibition of the folate receptor pathway
|
|
CN101784565B
(zh)
|
2007-06-25 |
2014-12-10 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
CN101139613B
(zh)
|
2007-08-01 |
2011-06-08 |
姜荣锡 |
抗肿瘤二元多肽及其应用与制备方法
|
|
JP2011506371A
(ja)
*
|
2007-12-12 |
2011-03-03 |
ピンチェル ソチエタ・レスポンサビリタ・リミタータ |
抗Ｆａｓリガンド抗体を含有する天疱瘡の治療薬
|
|
BRPI0821401A2
(pt)
|
2007-12-21 |
2014-10-14 |
Novartis Ag |
Compostos orgânicos
|
|
EP2241578B1
(en)
|
2008-01-11 |
2016-04-20 |
The University of Tokyo |
Anti-cldn6 antibody
|
|
EP2238154B1
(en)
|
2008-01-18 |
2015-09-16 |
Bio-Rad Laboratories, Inc. |
Enhanced purification of phosphorylated and non-phosphorylated biomolecules by apatite chromatography
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
WO2009132081A2
(en)
|
2008-04-24 |
2009-10-29 |
The Research Foundation Of State University Of New York |
Monoclonal antibody-based targeting of folate receptors
|
|
NZ610239A
(en)
|
2008-04-30 |
2014-11-28 |
Immunogen Inc |
Cross-linkers and their uses
|
|
SG189817A1
(en)
|
2008-04-30 |
2013-05-31 |
Immunogen Inc |
Potent conjugates and hydrophilic linkers
|
|
US8383351B2
(en)
|
2008-06-11 |
2013-02-26 |
Oxford Brookes University |
Antibody to inhibin/ activin β-B subunit
|
|
ES3029483T3
(en)
|
2008-09-17 |
2025-06-24 |
Endocyte Inc |
Folate receptor binding conjugates of antifolates
|
|
WO2010033913A1
(en)
|
2008-09-22 |
2010-03-25 |
Icb International, Inc. |
Antibodies, analogs and uses thereof
|
|
CN101440130B
(zh)
|
2008-11-21 |
2011-07-27 |
中国人民解放军第四军医大学 |
一种抗人IL-13Rα2单克隆抗体的重链和轻链的可变区
|
|
SI2378876T1
(sl)
|
2008-12-19 |
2019-05-31 |
Medicis Pharmaceutical Corporation |
Formulacije z nižjo dozirno jakostjo imikvimoda in kratki odmerni režimi za zdravljenje aktinične keratoze
|
|
AU2010229924B2
(en)
|
2009-03-24 |
2016-07-21 |
Plus Therapeutics Inc. |
Devices and methods of cell capture and analysis
|
|
WO2011016238A1
(en)
|
2009-08-06 |
2011-02-10 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
KR20120089863A
(ko)
*
|
2009-10-09 |
2012-08-14 |
사노피 |
“개선된 당화반응 최종 생성물에 대한 수용체”에 결합하기 위한 폴리펩타이드 및 이를 포함하는 조성물 및 방법
|
|
US9175086B2
(en)
|
2010-02-10 |
2015-11-03 |
Immunogen, Inc. |
CD20 antibodies and uses thereof
|
|
TWI622402B
(zh)
*
|
2010-02-24 |
2018-05-01 |
免疫遺傳股份有限公司 |
葉酸受體１抗體類和免疫共軛物類及彼等之用途
|
|
AR080795A1
(es)
*
|
2010-03-24 |
2012-05-09 |
Genentech Inc |
Anticuerpos anti-lrp6 (proteina relacionada con el receptor ldl tipo 6)
|
|
CN103347537A
(zh)
|
2010-10-20 |
2013-10-09 |
莫弗泰克股份有限公司 |
抗叶酸受体α抗体糖型
|
|
MX343607B
(es)
|
2010-11-05 |
2016-11-11 |
Morphotek Inc |
Receptor alfa de folato como marcador de diagnóstico y pronóstico para cánceres que expresan receptor alfa de folato.
|
|
ME03353B
(me)
|
2011-03-29 |
2019-10-20 |
Immunogen Inc |
Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
|
|
AU2012236403B2
(en)
|
2011-03-29 |
2016-08-04 |
Immunogen, Inc. |
Process for manufacturing conjugates of improved homogeneity
|
|
BR112013025415B1
(pt)
|
2011-04-01 |
2021-03-16 |
Immunogen, Inc |
uso de um imunoconjugado antirreceptor de folato 1 (folr1)
|
|
WO2012138749A1
(en)
|
2011-04-04 |
2012-10-11 |
Immunogen, Inc. |
Methods for decreasing ocular toxicity of antibody drug conjugates
|
|
WO2012145112A2
(en)
|
2011-04-18 |
2012-10-26 |
Immunogen, Inc. |
Novel maytansinoid derivatives with sulfoxide linker
|
|
EP2524929A1
(en)
|
2011-05-17 |
2012-11-21 |
Sanofi |
Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms
|
|
SI2731972T1
(en)
|
2011-07-15 |
2018-04-30 |
Eisai R&D Management Co., Ltd. |
Anti-folate receptor alpha antibodies and uses thereof
|
|
US9200073B2
(en)
|
2012-08-31 |
2015-12-01 |
Immunogen, Inc. |
Diagnostic assays and kits for detection of folate receptor 1
|
|
WO2014055842A1
(en)
|
2012-10-04 |
2014-04-10 |
Immunogen, Inc. |
Process for preparing stable antibody maytansinoid conjugates
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
SG11201509043RA
(en)
|
2013-05-14 |
2015-12-30 |
Immunogen Inc |
Anti-folr1 immunoconjugate dosing regimens
|
|
US20160209412A1
(en)
|
2013-08-23 |
2016-07-21 |
Nuclea Biotechnologies, Inc. |
Msia-srm assay for biomarker analysis
|
|
CN113150145B
(zh)
|
2013-08-30 |
2025-02-14 |
伊缪诺金公司 |
用于检测叶酸受体1的抗体和测定
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
PL3055332T3
(pl)
|
2013-10-08 |
2020-02-28 |
Immunogen, Inc. |
Schematy dawkowania immunokoniugatu anty-FOLR1
|
|
US20150297744A1
(en)
|
2014-03-28 |
2015-10-22 |
Immunogen, Inc. |
Anti-FOLR1 Immunoconjugate Dosing Regimens
|
|
WO2016004233A2
(en)
|
2014-07-01 |
2016-01-07 |
Expression Pathology, Inc. |
Srm assays to chemotherapy targets
|
|
SG11201701328XA
(en)
|
2014-09-02 |
2017-03-30 |
Immunogen Inc |
Methods for formulating antibody drug conjugate compositions
|
|
CN116440279B
(zh)
|
2015-09-17 |
2026-02-24 |
伊缪诺金公司 |
包含抗folr1免疫缀合物的治疗组合
|
|
ES2716900T3
(es)
|
2015-11-06 |
2019-06-17 |
Promise Advanced Proteomics |
Un método para cuantificar anticuerpos anti-TNF
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|
|
US20200284810A1
(en)
|
2017-09-05 |
2020-09-10 |
Immunogen, Inc. |
Methods for detection of folate receptor 1 in a patient sample
|
|
EP3684409A4
(en)
|
2017-09-22 |
2021-06-23 |
Immunogen, Inc. |
SEPARATION OF TRIPLE LIGHT CHAIN ANTIBODIES USING CATION EXCHANGE CHROMATOGRAPHY
|
|
US11274121B2
(en)
|
2018-01-12 |
2022-03-15 |
Immunogen, Inc. |
Methods for antibody drug conjugation, purification, and formulation
|
|
MA55818A
(fr)
|
2019-04-29 |
2022-03-16 |
Immunogen Inc |
Anticorps et immunoconjugués de fr-alpha biparatopique
|